Capital Advisors Ltd’s Core Laboratories CLB Stock Holding History

Capital Advisors Ltd’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	–	–	1376
2025 Q3	$0	Buy	+1	New	+$12	﹤0.01%	1377

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Advisors Ltd's CLB Position: Q4 2025 in Review

Capital Advisors Ltd sold out of Core Laboratories (CLB) in Q4 2025, closing a stake of 1 share.

Capital Advisors Ltd first reported a position in CLB in Q3 2025 and held it in 1 quarter. The position peaked at $0 in Q3 2025. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.

Capital Advisors Ltd reported no remaining Core Laboratories position as of Q4 2025 after selling out during the quarter.
Capital Advisors Ltd sold 1 Core Laboratories share in Q4 2025.
Capital Advisors Ltd first reported a position in Core Laboratories in Q3 2025 and held it in 1 quarter.
Capital Advisors Ltd's Core Laboratories position peaked at $0 in Q3 2025.
187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.

Based on Capital Advisors Ltd's 13F filing for Q4 2025, filed 21 Jan 2026.